Cadbel Pharmaceuticals Private Limited
About Cadbel Pharmaceuticals Private Limited
Data last updated:
Cadbel Pharmaceuticals Private Limited is a private limited company based in Bengaluru, Karnataka, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 04 July 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U36990KA2016PTC094674. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹4.5 Lakh. It is led by directors including Basavaraju Mohan Kumar and Mudugare Nataraj Kavya.
Its last annual general meeting (AGM) was held on 29 September 2018, and its latest financial statements are for the year ended 31 March 2018. The registered office is at #1/1 4/2 4/3 Ground Floor Makali Bengaluru North, Karnataka, India – 562123.
As per the financials filed for FY 2018, the company reported a revenue of ₹7.3 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹1.02 Lakh (net margin -14%) and EBITDA of ₹86,399 (EBITDA margin 11.8%).
As per MCA filings, the company has open charges of ₹24 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Cadbel Pharmaceuticals Private Limited's registered office is in Bengaluru, Karnataka. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address#1/1 4/2 4/3 Ground Floor Makali Bengaluru North, Karnataka, India – 562123
- IndustryPharma, Pharmaceutical Retailers & Distributors
To see the full contact details of Cadbel Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Cadbel Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Cadbel Pharmaceuticals Private Limited, buy the company report.
Financials of Cadbel Pharmaceuticals Private Limited
FY 2018 filings availableCadbel Pharmaceuticals Private Limited reported revenue of ₹7.3 Lakh (up 804% YoY) for FY 2018.
Compounded Annual Growth Rate (CAGR)
Revenue rose 804% in the latest year. EBITDA rose 138% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2017-18 | FY 2016-17 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | ||
| Other Income | ||
| Total Revenue | ||
| Cost of Materials Consumed | ||
| Employee Benefit Expense | ||
| Finance Costs | ||
| Depreciation and Amortisation | ||
| Other Expenses | ||
| Total Expenses | ||
| EBITDA | ₹86,399 | |
| Profit Before Tax | ||
| Tax Expense | ||
| Net Profit (PAT) | -₹1.02 Lakh | |
| Balance Sheet | ||
| Share Capital | ||
| Reserves and Surplus | ||
| Net Worth (Total Equity) | ||
| Long-term Borrowings | ||
| Short-term Borrowings | ||
| Trade Payables | ||
| Total Liabilities | ||
| Fixed Assets | ||
| Investments | ||
| Inventories | ||
| Trade Receivables | ||
| Cash and Bank Balance | ||
| Total Assets | ||
Financial Ratios
| Metrics | FY 2017-18 | FY 2016-17 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 11.8% | |
| Net Profit Margin | -14% | |
| Return on Equity (ROE) | ||
| Return on Capital Employed (ROCE) | ||
| Return on Assets (ROA) | ||
| Liquidity and Debt | ||
| Current Ratio | ||
| Quick Ratio | ||
| Debt-to-Equity Ratio | ||
| Interest Coverage Ratio | ||
| Efficiency and Growth | ||
| Asset Turnover | ||
| Receivable Days | ||
| Payable Days | ||
| Inventory Days | ||
| Revenue Growth | ||
| Net Profit Growth | ||
To see the full financial statements and ratios of Cadbel Pharmaceuticals Private Limited, buy the company report.
Board of directors of Cadbel Pharmaceuticals Private Limited
Cadbel Pharmaceuticals has 4 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Basavaraju Mohan Kumar | Director | 04 Jul 2016 | 10 Years 3 Months | Current |
| Mudugare Nataraj Kavya | Director | 04 Jul 2016 | 10 Years 3 Months | Current |
| Suvarna | Additional Director | 16 Jan 2019 | 7 Years 9 Months | Current |
| Shreyas Hastantram Nagendrababu | Additional Director | 16 Jan 2019 | 7 Years 9 Months | Current |
Peer comparison
Cadbel Pharmaceuticals Private Limited is compared with the 4 companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nutriclox Pharmaceuticals Private Limited | ₹7.36 Lakh (FY 2025) | -34.0% | Patna, Bihar, India | |||
| Cadbel Pharmaceuticals Private Limitedthis company | ₹7.3 Lakh (FY 2018) | -₹1.02 Lakh | -14% | 804.0% | Bengaluru, Karnataka, India | |
| Oplent Pharmaceuticals Private Limited | ₹7.29 Lakh (FY 2022) | Arrah, Bihar, India | ||||
| SP Pharmaceuticals Private Limited | ₹7.29 Lakh (FY 2024) | 7.0% | Ulhasnagar, Maharashtra, India | |||
| Accedo Pharmaceuticals Private Limited | ₹7.27 Lakh (FY 2017) | 85.0% | Kolkata, West Bengal, India |
To see the full peer comparison of Cadbel Pharmaceuticals Private Limited, buy the company report.
Auditor
Cadbel Pharmaceuticals Private Limited is audited by KONDASATHYANARAYANA SETTYRAMA MURTHY for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| KONDASATHYANARAYANA SETTYRAMA MURTHY | FY 2017 | 207853 |
Shareholding
The shareholding of Cadbel Pharmaceuticals Private Limited is on record for FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 |
|---|---|
| Promoters | |
| Domestic institutional investors (DII) | |
| Foreign institutional investors (FII) | |
| Public | |
| Others |
To see the full shareholding pattern of Cadbel Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 10 Nov 2017 | 100282391 | State Bank of India | ₹24 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Cadbel Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cadbel Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Cadbel Pharmaceuticals has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
To see the full GST registrations and return filing status of Cadbel Pharmaceuticals Private Limited, buy the company report.
Recent activity
Cadbel Pharmaceuticals Private Limited has 6 board changes on record since 2016: 4 appointments and 2 cessations. The latest: Suvarna ceased to be Additional Director on 15 Mar 2020.
Frequently asked questions
Cadbel Pharmaceuticals is an active private limited company based in Bengaluru, Karnataka, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 04 July 2016 (10+ years old) and is registered under CIN U36990KA2016PTC094674.
Cadbel Pharmaceuticals has 4 current directors:
- Basavaraju Mohan Kumar - Director
- Mudugare Nataraj Kavya - Director
- Suvarna - Additional Director
- Shreyas Hastantram Nagendrababu - Additional Director
The latest financial statements of Cadbel Pharmaceuticals on record with the MCA are for the year ended 31 March 2018. Its last annual general meeting was held on 29 September 2018. Year-wise statements from FY 2017 are in the company report.
No. Cadbel Pharmaceuticals has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Cadbel Pharmaceuticals is U36990KA2016PTC094674. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cadbel Pharmaceuticals was incorporated on 04 July 2016, making it 10+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Cadbel Pharmaceuticals by revenue are Nutriclox Pharmaceuticals Private Limited, Oplent Pharmaceuticals Private Limited, SP Pharmaceuticals Private Limited, Accedo Pharmaceuticals Private Limited, all in the Pharma industry (Pharma Retail and Distribution, Pharmaceuticals), with the same principal business activity (wholesale trading).
Suvarna ceased to be Additional Director on 15 Mar 2020. Shreyas Hastantram Nagendrababu ceased to be Additional Director on 31 Oct 2019. Shreyas Hastantram Nagendrababu was appointed as Additional Director on 16 Jan 2019. Cadbel Pharmaceuticals has 6 board changes on record in total.
The registered office of Cadbel Pharmaceuticals is at #11 42 43 Ground Floor Makali Bengaluru North, Karnataka, India – 562123.
Cadbel Pharmaceuticals operates in the pharma industry, in the pharmaceutical retailers and distributors segment.
Cadbel Pharmaceuticals has open charges of ₹24 Lakh and no satisfied charges on record as per latest MCA filings.